ALPHA TRIBE

Bafna Pharmaceuticals LimitedBoard Meeting, 11-11-2025: Outcome of Board Meeting

11-11-2025 | 05:46 pm

Bafna Pharmaceuticals' board held a meeting and approved the financial results for the quarter and half-year ended September 30, 2025. For the half-year, revenue from operations stood at ₹70.09 Cr, with a profit of ₹6.51 Cr and EPS of ₹2.75.

No comments yet. Be the first to comment!

All announcements from Bafna Pharmaceuticals Limited